May 24, 2022
Corporate Welfare Watch
  • Home
  • About Us
  • Corporate Welfare
  • CWW Database
    • Database: Head Companies
    • Database: Original Recipients
  • CW Schemes
  • Publications
  • Contact us

NHS

Corporate welfare General

Tackling the negative effects of PFI: Conflicting reports on policy advice

November 15, 2018

The Centre for Health and the Public Interest (CHPI) has recently published a report on private finance initiatives (PFI).  The report, intended for policy-makers, outlines five options for coping with PFI and its lasting effects, […]

Corporate welfare General

NHS expenditure on outsourced patient scans: Money that could be money better spent?

October 15, 2018

Highlighting findings from the Royal College of Radiologists, ‘Clinical Radiology UK Workforce Census 2017 Report’, a recent BMJ news article calls attention to the rising expenditure by the NHS on outsourced radiology patient scans. With […]

UK government gives £86 million pounds to private firms that pursue medical technology for the NHS.
Follow the money

Government Gives £86 Million to Firms Working on Medical Technology for Use in NHS

July 14, 2017

The UK government will offer up to £86 million in funding to UK firms that work to develop ‘medical breakthroughs.’ Funds will go to small and medium sized enterprises (SMEs) that wish to develop and […]

Big Pharma may leave UK if NHS does not receive more funding.
Corporate welfare General

Major Drug Companies May Leave UK if NHS Does Not Receive More Funding

April 27, 2017

The Times reports that The Association of the British Pharmaceutical Industry (ABPI) has warned that major drug companies may leave Britain if the NHS is not funded an additional £20 billion per year. The organisation […]

Corporate welfare General

UK pharma firms accused of illegal deals to hike price of life-saving drug from The Guardian

March 2, 2017

Piece from the Guardian pointing to an investigation by the competition authority into price fixing within the pharmaceutical industry. Actavis charged NHS 80% more for hydrocortisone tablets after incentivising rival Concordia not to launch its […]

Corporate welfare General

Martin Shkreli: entrepreneur defends decision to raise price of life-saving drug 50-fold | Business | The Guardian

September 22, 2015

The cost of drugs and other medical equipment is of growing concern to both public health systems and private health insurance companies. Regarding the former, pharmaceutical companies can push up the price of drugs in […]

Tags

agricultural subsidies amazon Automotive industry bank bailouts big pharma Brexit CAP Capita carillion Corporate tax corporate welfare Corporate welfare debate Corporation tax CWW electricity electric vehicles energy Facebook farming Finance Ford fossil fuel Google health health care in-work benefits industrial strategy newsletter NHS Nissan oil industry Outsourcing pfi Privatisation procurement steel industry subsidies subsidy Tata Steel tax avoidance tax credits Tesco train companies wage subsidies Wales

Copyright: Corporate Welfare Watch 2017